Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

RAD001 and Neurocognition in PTEN Hamartoma Tumor Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02991807
Recruitment Status : Active, not recruiting
First Posted : December 14, 2016
Last Update Posted : February 4, 2021
Sponsor:
Collaborators:
National Institutes of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
Office of Rare Diseases (ORD)
National Center for Advancing Translational Science (NCATS)
Novartis Pharmaceuticals
PTEN Research
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Information provided by (Responsible Party):
Mustafa Sahin, Boston Children's Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : September 2021
Estimated Study Completion Date : December 2021